Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Anti-Tumorigenic Effects of Sea Buckthorn Root Extracts on Head and Neck Cancer Cells-A Systematic Analysis

Gazizova A., Gronbach M., Oppermann C., Kragl U., Engel N.

Laboratory Study on Hip, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Mol Sci (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40429771
PMCID
PMC12110798
DOI
10.3390/ijms26104625

Abstract (original English)

Chemotherapy is a common treatment method for cancer that is often associated with strong side effects. To reduce these, research on extracts from medicinal plants and their active ingredients has been conducted. Although sea buckthorn ( Hippophae rhamnoides ) is a well-established medicinal plant, little is known about the chemical components responsible for its putative anticancer activity. This study focuses on both chemical and medical analyses of methanolic sea buckthorn root extracts. Cell viability measurements were performed on head and neck cancer cell lines, as well as non-tumorigenic control cells. Microwave and classical extractions under reflux were used to prepare the methanolic extracts. LC/MS and NMR were used to determine the structures of the molecules contained within these extracts. The aqueous phase of one sea buckthorn root extract reduced the viability of cancer cells, whereas the viability of non-tumorigenic control cells remained unaltered. The cell cycle phases of cancer cells treated with the extract shifted in comparison to control treatment. After 24 h, the number of cells in proliferative phases had increased. Two fractions of the extract that evoked alterations were identified. After a 48 h treatment, one of the fractions showed a higher number of apoptotic cells than the control. LC/MS and NMR analyses were conducted to attempt to identify the ac

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cell Line, TumorHumansHippophaePlant RootsHead and Neck NeoplasmsPlant ExtractsAntineoplastic Agents, PhytogenicChromatography, LiquidMagnetic Resonance SpectroscopyCell Cycle

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research